Related Experiment Video
Updated: Aug 26, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?
1Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. e.musgrove@garvan.org.au
Abstract:
Recent data have suggested the epidermal-growth-factor receptor (EGFR) as a point of convergence for several different classes of receptor. Civenni and colleagues have now demonstrated crosstalk between Wnt signalling and the EGFR, showing that in breast epithelial cells Wnts activate downstream targets of the EGFR, including cyclin D1. Given the role of members of these pathways in the aetiology of breast cancer and as markers of outcome and potential therapeutic targets in breast cancer, this observation has a number of potential implications important for both the basic biology of breast cancer and the clinical management of the disease.
Related Concept Videos
Canonical Wnt Signaling Pathway
Mitogens and the Cell Cycle
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

